Clinical Trial Update: Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia [NA]

View source ↗

Summary

A clinical trial is investigating the use of stereotactic ablative radiotherapy for refractory ventricular tachycardia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Tachycardia

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Radiotherapy; Complications, Ventricular Tachycardia | NA | Status: RECRUITING